Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 176 entries
Sorted by: Best Match Show Resources per page
The D-score: a metric for interpreting the early development of infants and toddlers across global settings.

BMJ global health

Weber AM, Rubio-Codina M, Walker SP, van Buuren S, Eekhout I, Grantham-McGregor SM, Araujo MC, Chang SM, Fernald LC, Hamadani JD, Hanlon C, Karam SM, Lozoff B, Ratsifandrihamanana L, Richter L, Black MM.
PMID: 31803508
BMJ Glob Health. 2019 Nov 19;4(6):e001724. doi: 10.1136/bmjgh-2019-001724. eCollection 2019.

INTRODUCTION: Early childhood development can be described by an underlying latent construct. Global comparisons of children's development are hindered by the lack of a validated metric that is comparable across cultures and contexts, especially for children under age 3...

Cite
Weber AM, Rubio-Codina M, Walker SP, et al. The D-score: a metric for interpreting the early development of infants and toddlers across global settings. BMJ Glob Health. 2019;4(6):e001724doi: 10.1136/bmjgh-2019-001724.
Weber, A. M., Rubio-Codina, M., Walker, S. P., van Buuren, S., Eekhout, I., Grantham-McGregor, S. M., Araujo, M. C., Chang, S. M., Fernald, L. C., Hamadani, J. D., Hanlon, C., Karam, S. M., Lozoff, B., Ratsifandrihamanana, L., Richter, L., Black, M. M. (2019). The D-score: a metric for interpreting the early development of infants and toddlers across global settings. BMJ global health, 4(6), e001724. https://doi.org/10.1136/bmjgh-2019-001724
Weber, Ann M, et al. "The D-score: a metric for interpreting the early development of infants and toddlers across global settings." BMJ global health vol. 4,6 (2019): e001724. doi: https://doi.org/10.1136/bmjgh-2019-001724
Weber AM, Rubio-Codina M, Walker SP, van Buuren S, Eekhout I, Grantham-McGregor SM, Araujo MC, Chang SM, Fernald LC, Hamadani JD, Hanlon C, Karam SM, Lozoff B, Ratsifandrihamanana L, Richter L, Black MM. The D-score: a metric for interpreting the early development of infants and toddlers across global settings. BMJ Glob Health. 2019 Nov 19;4(6):e001724. doi: 10.1136/bmjgh-2019-001724. eCollection 2019. PMID: 31803508; PMCID: PMC6882553.
Copy Download .nbib Format: NLM
Profiling of Protein Degraders in Cultures of Human Gut Microbiota.

Frontiers in microbiology

Amaretti A, Gozzoli C, Simone M, Raimondi S, Righini L, Pérez-Brocal V, García-López R, Moya A, Rossi M.
PMID: 31803157
Front Microbiol. 2019 Nov 15;10:2614. doi: 10.3389/fmicb.2019.02614. eCollection 2019.

Unabsorbed proteins reach the colon and are fermented by the microbiota, yielding a variety of harmful metabolites. In the present study, a 16S rRNA gene survey identified the bacterial taxa flourishing in 11 batch fermentations with proteins and peptones...

Cite
Amaretti A, Gozzoli C, Simone M, et al. Profiling of Protein Degraders in Cultures of Human Gut Microbiota. Front Microbiol. 2019;10:2614doi: 10.3389/fmicb.2019.02614.
Amaretti, A., Gozzoli, C., Simone, M., Raimondi, S., Righini, L., Pérez-Brocal, V., García-López, R., Moya, A., & Rossi, M. (2019). Profiling of Protein Degraders in Cultures of Human Gut Microbiota. Frontiers in microbiology, 102614. https://doi.org/10.3389/fmicb.2019.02614
Amaretti, Alberto, et al. "Profiling of Protein Degraders in Cultures of Human Gut Microbiota." Frontiers in microbiology vol. 10 (2019): 2614. doi: https://doi.org/10.3389/fmicb.2019.02614
Amaretti A, Gozzoli C, Simone M, Raimondi S, Righini L, Pérez-Brocal V, García-López R, Moya A, Rossi M. Profiling of Protein Degraders in Cultures of Human Gut Microbiota. Front Microbiol. 2019 Nov 15;10:2614. doi: 10.3389/fmicb.2019.02614. eCollection 2019. PMID: 31803157; PMCID: PMC6874058.
Copy Download .nbib Format: NLM
An Embodied Tutoring System for Literal vs. Metaphorical Concepts.

Frontiers in psychology

Sionti M, Schack T, Aloimonos Y.
PMID: 30546328
Front Psychol. 2018 Nov 28;9:2254. doi: 10.3389/fpsyg.2018.02254. eCollection 2018.

In this paper we combine motion captured data with linguistic notions (preliminary study) in a game-like tutoring system (study 1), in order to help elementary school students to better differentiate literal from metaphorical uses of motion verbs, based on...

Cite
Sionti M, Schack T, Aloimonos Y. An Embodied Tutoring System for Literal vs. Metaphorical Concepts. Front Psychol. 2018;9:2254doi: 10.3389/fpsyg.2018.02254.
Sionti, M., Schack, T., & Aloimonos, Y. (2018). An Embodied Tutoring System for Literal vs. Metaphorical Concepts. Frontiers in psychology, 92254. https://doi.org/10.3389/fpsyg.2018.02254
Sionti, Marietta, et al. "An Embodied Tutoring System for Literal vs. Metaphorical Concepts." Frontiers in psychology vol. 9 (2018): 2254. doi: https://doi.org/10.3389/fpsyg.2018.02254
Sionti M, Schack T, Aloimonos Y. An Embodied Tutoring System for Literal vs. Metaphorical Concepts. Front Psychol. 2018 Nov 28;9:2254. doi: 10.3389/fpsyg.2018.02254. eCollection 2018. PMID: 30546328; PMCID: PMC6280681.
Copy Download .nbib Format: NLM
Feasibility of narrative exposure therapy in an outpatient day treatment programme for refugees: improvement in symptoms and global functioning.

European journal of psychotraumatology

de la Rie SM, Smid GE, van der Aa N, van Est LAC, Bisseling E, Boelen PA.
PMID: 33029303
Eur J Psychotraumatol. 2020 Jun 16;11(1):1759983. doi: 10.1080/20008198.2020.1759983.

BACKGROUND:  Refugees are at high risk for developing post-traumatic stress disorder (PTSD). Narrative exposure therapy (NET) is an evidence-based treatment of PTSD, designed for patients exposed to (multiple) traumatic events and recommended for patients with culturally diverse backgrounds. In...

Cite
de la Rie SM, Smid GE, van der Aa N, et al. Feasibility of narrative exposure therapy in an outpatient day treatment programme for refugees: improvement in symptoms and global functioning. Eur J Psychotraumatol. 2020;11(1):1759983doi: 10.1080/20008198.2020.1759983.
de la Rie, S. M., Smid, G. E., van der Aa, N., van Est, L. A. C., Bisseling, E., & Boelen, P. A. (2020). Feasibility of narrative exposure therapy in an outpatient day treatment programme for refugees: improvement in symptoms and global functioning. European journal of psychotraumatology, 11(1), 1759983. https://doi.org/10.1080/20008198.2020.1759983
de la Rie, Simone M, et al. "Feasibility of narrative exposure therapy in an outpatient day treatment programme for refugees: improvement in symptoms and global functioning." European journal of psychotraumatology vol. 11,1 (2020): 1759983. doi: https://doi.org/10.1080/20008198.2020.1759983
de la Rie SM, Smid GE, van der Aa N, van Est LAC, Bisseling E, Boelen PA. Feasibility of narrative exposure therapy in an outpatient day treatment programme for refugees: improvement in symptoms and global functioning. Eur J Psychotraumatol. 2020 Jun 16;11(1):1759983. doi: 10.1080/20008198.2020.1759983. PMID: 33029303; PMCID: PMC7473203.
Copy Download .nbib Format: NLM
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.

European journal of cancer (Oxford, England : 1990)

Goldinger SM, Buder-Bakhaya K, Lo SN, Forschner A, McKean M, Zimmer L, Khoo C, Dummer R, Eroglu Z, Buchbinder EI, Ascierto PA, Gutzmer R, Rozeman EA, Hoeller C, Johnson DB, Gesierich A, Kölblinger P, Bennannoune N, Cohen JV, Kähler KC, Wilson MA, Cebon J, Atkinson V, Smith JL, Michielin O, Long GV, Hassel JC, Weide B, Haydu LE, Schadendorf D, McArthur G, Ott PA, Blank C, Robert C, Sullivan R, Hauschild A, Carlino MS, Garbe C, Davies MA, Menzies AM.
PMID: 34952480
Eur J Cancer. 2021 Dec 21;162:22-33. doi: 10.1016/j.ejca.2021.11.022. Epub 2021 Dec 21.

INTRODUCTION: Despite remarkably improved outcomes with immune checkpoint inhibition, many patients with metastatic melanoma will eventually require further therapy. Chemotherapy has limited activity when used first-line but can alter the tumour microenvironment and does improve efficacy when used in...

Cite
Goldinger SM, Buder-Bakhaya K, Lo SN, et al. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. Eur J Cancer. 2021;162:22-33doi: 10.1016/j.ejca.2021.11.022.
Goldinger, S. M., Buder-Bakhaya, K., Lo, S. N., Forschner, A., McKean, M., Zimmer, L., Khoo, C., Dummer, R., Eroglu, Z., Buchbinder, E. I., Ascierto, P. A., Gutzmer, R., Rozeman, E. A., Hoeller, C., Johnson, D. B., Gesierich, A., Kölblinger, P., Bennannoune, N., Cohen, J. V., Kähler, K. C., Wilson, M. A., Cebon, J., Atkinson, V., Smith, J. L., Michielin, O., Long, G. V., Hassel, J. C., Weide, B., Haydu, L. E., Schadendorf, D., McArthur, G., Ott, P. A., Blank, C., Robert, C., Sullivan, R., Hauschild, A., Carlino, M. S., Garbe, C., Davies, M. A., & Menzies, A. M. (2021). Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. European journal of cancer (Oxford, England : 1990), 16222-33. https://doi.org/10.1016/j.ejca.2021.11.022
Goldinger, Simone M, et al. "Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis." European journal of cancer (Oxford, England : 1990) vol. 162 (2021): 22-33. doi: https://doi.org/10.1016/j.ejca.2021.11.022
Goldinger SM, Buder-Bakhaya K, Lo SN, Forschner A, McKean M, Zimmer L, Khoo C, Dummer R, Eroglu Z, Buchbinder EI, Ascierto PA, Gutzmer R, Rozeman EA, Hoeller C, Johnson DB, Gesierich A, Kölblinger P, Bennannoune N, Cohen JV, Kähler KC, Wilson MA, Cebon J, Atkinson V, Smith JL, Michielin O, Long GV, Hassel JC, Weide B, Haydu LE, Schadendorf D, McArthur G, Ott PA, Blank C, Robert C, Sullivan R, Hauschild A, Carlino MS, Garbe C, Davies MA, Menzies AM. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. Eur J Cancer. 2021 Dec 21;162:22-33. doi: 10.1016/j.ejca.2021.11.022. Epub 2021 Dec 21. PMID: 34952480.
Copy Download .nbib Format: NLM
The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination.

Cancers

Serratì S, Porcelli L, Fragassi F, Garofoli M, Di Fonte R, Fucci L, Iacobazzi RM, Palazzo A, Margheri F, Cristiani G, Albano A, De Luca R, Altomare DF, Simone M, Azzariti A.
PMID: 34065529
Cancers (Basel). 2021 May 20;13(10). doi: 10.3390/cancers13102505.

Advanced colorectal cancer (CRC) is highly metastatic and often results in peritoneal dissemination. The extracellular vesicles (EVs) released by cancer cells in the microenvironment are important mediators of tumor metastasis. We investigated the contribution of EV-mediated interaction between peritoneal...

Cite
Serratì S, Porcelli L, Fragassi F, et al. The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination. Cancers (Basel). 2021;13(10)doi: 10.3390/cancers13102505.
Serratì, S., Porcelli, L., Fragassi, F., Garofoli, M., Di Fonte, R., Fucci, L., Iacobazzi, R. M., Palazzo, A., Margheri, F., Cristiani, G., Albano, A., De Luca, R., Altomare, D. F., Simone, M., & Azzariti, A. (2021). The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination. Cancers, 13(10), . https://doi.org/10.3390/cancers13102505
Serratì, Simona, et al. "The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination." Cancers vol. 13,10 (2021). doi: https://doi.org/10.3390/cancers13102505
Serratì S, Porcelli L, Fragassi F, Garofoli M, Di Fonte R, Fucci L, Iacobazzi RM, Palazzo A, Margheri F, Cristiani G, Albano A, De Luca R, Altomare DF, Simone M, Azzariti A. The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination. Cancers (Basel). 2021 May 20;13(10). doi: 10.3390/cancers13102505. PMID: 34065529; PMCID: PMC8161093.
Copy Download .nbib Format: NLM
Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential.

Biotechnology progress

Luo H, Li Y, Robbins D, Wang SC, Xi G, Cox M, Nicholson SM, Wei C, Pabst TM, Wang WK.
PMID: 33373106
Biotechnol Prog. 2021 May;37(3):e3119. doi: 10.1002/btpr.3119. Epub 2021 Jan 06.

Process-related impurities (PRIs) derived from manufacturing process should be minimized in final drug product. ICH Q3A provides a regulatory road map for PRIs but excludes biologic drugs like monoclonal antibodies (mAbs) that contain biological PRIs (e.g. host cell proteins...

Cite
Luo H, Li Y, Robbins D, et al. Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential. Biotechnol Prog. 2021;37(3):e3119doi: 10.1002/btpr.3119.
Luo, H., Li, Y., Robbins, D., Wang, S. C., Xi, G., Cox, M., Nicholson, S. M., Wei, C., Pabst, T. M., & Wang, W. K. (2021). Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential. Biotechnology progress, 37(3), e3119. https://doi.org/10.1002/btpr.3119
Luo, Haibin, et al. "Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential." Biotechnology progress vol. 37,3 (2021): e3119. doi: https://doi.org/10.1002/btpr.3119
Luo H, Li Y, Robbins D, Wang SC, Xi G, Cox M, Nicholson SM, Wei C, Pabst TM, Wang WK. Safety risk management for low molecular weight process-related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential. Biotechnol Prog. 2021 May;37(3):e3119. doi: 10.1002/btpr.3119. Epub 2021 Jan 06. PMID: 33373106; PMCID: PMC8365748.
Copy Download .nbib Format: NLM
Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity.

The EMBO journal

Wang B, Varela-Eirin M, Brandenburg SM, Hernandez-Segura A, van Vliet T, Jongbloed EM, Wilting SM, Ohtani N, Jager A, Demaria M.
PMID: 34985783
EMBO J. 2022 Jan 05;e108946. doi: 10.15252/embj.2021108946. Epub 2022 Jan 05.

Cellular senescence is a state of stable growth arrest and a desired outcome of tumor suppressive interventions. Treatment with many anti-cancer drugs can cause premature senescence of non-malignant cells. These therapy-induced senescent cells can have pro-tumorigenic and pro-disease functions...

Cite
Wang B, Varela-Eirin M, Brandenburg SM, et al. Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity. EMBO J. 2022;e108946doi: 10.15252/embj.2021108946.
Wang, B., Varela-Eirin, M., Brandenburg, S. M., Hernandez-Segura, A., van Vliet, T., Jongbloed, E. M., Wilting, S. M., Ohtani, N., Jager, A., & Demaria, M. (2022). Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity. The EMBO journal, e108946. https://doi.org/10.15252/embj.2021108946
Wang, Boshi, et al. "Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity." The EMBO journal vol. (2022): e108946. doi: https://doi.org/10.15252/embj.2021108946
Wang B, Varela-Eirin M, Brandenburg SM, Hernandez-Segura A, van Vliet T, Jongbloed EM, Wilting SM, Ohtani N, Jager A, Demaria M. Pharmacological CDK4/6 inhibition reveals a p53-dependent senescent state with restricted toxicity. EMBO J. 2022 Jan 05;e108946. doi: 10.15252/embj.2021108946. Epub 2022 Jan 05. PMID: 34985783.
Copy Download .nbib Format: NLM
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.

European journal of cancer (Oxford, England : 1990)

Goldinger SM, Buder-Bakhaya K, Lo SN, Forschner A, McKean M, Zimmer L, Khoo C, Dummer R, Eroglu Z, Buchbinder EI, Ascierto PA, Gutzmer R, Rozeman EA, Hoeller C, Johnson DB, Gesierich A, Kölblinger P, Bennannoune N, Cohen JV, Kähler KC, Wilson MA, Cebon J, Atkinson V, Smith JL, Michielin O, Long GV, Hassel JC, Weide B, Haydu LE, Schadendorf D, McArthur G, Ott PA, Blank C, Robert C, Sullivan R, Hauschild A, Carlino MS, Garbe C, Davies MA, Menzies AM.
PMID: 34952480
Eur J Cancer. 2021 Dec 21;162:22-33. doi: 10.1016/j.ejca.2021.11.022. Epub 2021 Dec 21.

INTRODUCTION: Despite remarkably improved outcomes with immune checkpoint inhibition, many patients with metastatic melanoma will eventually require further therapy. Chemotherapy has limited activity when used first-line but can alter the tumour microenvironment and does improve efficacy when used in...

Cite
Goldinger SM, Buder-Bakhaya K, Lo SN, et al. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. Eur J Cancer. 2021;162:22-33doi: 10.1016/j.ejca.2021.11.022.
Goldinger, S. M., Buder-Bakhaya, K., Lo, S. N., Forschner, A., McKean, M., Zimmer, L., Khoo, C., Dummer, R., Eroglu, Z., Buchbinder, E. I., Ascierto, P. A., Gutzmer, R., Rozeman, E. A., Hoeller, C., Johnson, D. B., Gesierich, A., Kölblinger, P., Bennannoune, N., Cohen, J. V., Kähler, K. C., Wilson, M. A., Cebon, J., Atkinson, V., Smith, J. L., Michielin, O., Long, G. V., Hassel, J. C., Weide, B., Haydu, L. E., Schadendorf, D., McArthur, G., Ott, P. A., Blank, C., Robert, C., Sullivan, R., Hauschild, A., Carlino, M. S., Garbe, C., Davies, M. A., & Menzies, A. M. (2021). Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. European journal of cancer (Oxford, England : 1990), 16222-33. https://doi.org/10.1016/j.ejca.2021.11.022
Goldinger, Simone M, et al. "Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis." European journal of cancer (Oxford, England : 1990) vol. 162 (2021): 22-33. doi: https://doi.org/10.1016/j.ejca.2021.11.022
Goldinger SM, Buder-Bakhaya K, Lo SN, Forschner A, McKean M, Zimmer L, Khoo C, Dummer R, Eroglu Z, Buchbinder EI, Ascierto PA, Gutzmer R, Rozeman EA, Hoeller C, Johnson DB, Gesierich A, Kölblinger P, Bennannoune N, Cohen JV, Kähler KC, Wilson MA, Cebon J, Atkinson V, Smith JL, Michielin O, Long GV, Hassel JC, Weide B, Haydu LE, Schadendorf D, McArthur G, Ott PA, Blank C, Robert C, Sullivan R, Hauschild A, Carlino MS, Garbe C, Davies MA, Menzies AM. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. Eur J Cancer. 2021 Dec 21;162:22-33. doi: 10.1016/j.ejca.2021.11.022. Epub 2021 Dec 21. PMID: 34952480.
Copy Download .nbib Format: NLM
Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice.

Frontiers in aging neuroscience

den Hoedt S, Crivelli SM, Leijten FPJ, Losen M, Stevens JAA, Mané-Damas M, de Vries HE, Walter J, Mirzaian M, Sijbrands EJG, Aerts JMFG, Verhoeven AJM, Martinez-Martinez P, Mulder MT.
PMID: 34776936
Front Aging Neurosci. 2021 Oct 27;13:765252. doi: 10.3389/fnagi.2021.765252. eCollection 2021.

Apolipoprotein ε4 (

Cite
den Hoedt S, Crivelli SM, Leijten FPJ, et al. Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice. Front Aging Neurosci. 2021;13:765252doi: 10.3389/fnagi.2021.765252.
den Hoedt, S., Crivelli, S. M., Leijten, F. P. J., Losen, M., Stevens, J. A. A., Mané-Damas, M., de Vries, H. E., Walter, J., Mirzaian, M., Sijbrands, E. J. G., Aerts, J. M. F. G., Verhoeven, A. J. M., Martinez-Martinez, P., & Mulder, M. T. (2021). Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice. Frontiers in aging neuroscience, 13765252. https://doi.org/10.3389/fnagi.2021.765252
den Hoedt, Sandra, et al. "Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice." Frontiers in aging neuroscience vol. 13 (2021): 765252. doi: https://doi.org/10.3389/fnagi.2021.765252
den Hoedt S, Crivelli SM, Leijten FPJ, Losen M, Stevens JAA, Mané-Damas M, de Vries HE, Walter J, Mirzaian M, Sijbrands EJG, Aerts JMFG, Verhoeven AJM, Martinez-Martinez P, Mulder MT. Effects of Sex, Age, and Apolipoprotein E Genotype on Brain Ceramides and Sphingosine-1-Phosphate in Alzheimer's Disease and Control Mice. Front Aging Neurosci. 2021 Oct 27;13:765252. doi: 10.3389/fnagi.2021.765252. eCollection 2021. PMID: 34776936; PMCID: PMC8579780.
Copy Download .nbib Format: NLM
[Ethics and health professions].

Boletin de la Asociacion Medica de Puerto Rico

Sifontes JE.
PMID: 6932875
Bol Asoc Med P R. 1980 Jul;72(7):376-9.

No abstract available.

Cite
Sifontes JE. La ética y las profesiones de la salud. [Ethics and health professions]. Bol Asoc Med P R. 1980;72(7):376-9
Sifontes, J. E. (1980). La ética y las profesiones de la salud. [Ethics and health professions]. Boletin de la Asociacion Medica de Puerto Rico, 72(7), 376-9.
Sifontes, J E. "La ética y las profesiones de la salud." [Ethics and health professions]. Boletin de la Asociacion Medica de Puerto Rico vol. 72,7 (1980): 376-9.
Sifontes JE. La ética y las profesiones de la salud. [Ethics and health professions]. Bol Asoc Med P R. 1980 Jul;72(7):376-9. Spanish. PMID: 6932875.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in neurology

Simone M, Trabacca A, Panzeri E, Losito L, Citterio A, Bassi MT.
PMID: 30581417
Front Neurol. 2018 Dec 07;9:1078. doi: 10.3389/fneur.2018.01078. eCollection 2018.

This paper describes the clinical evolution and the novel genetic findings in a

Cite
Simone M, Trabacca A, Panzeri E, et al. . Front Neurol. 2018;9:1078doi: 10.3389/fneur.2018.01078.
Simone, M., Trabacca, A., Panzeri, E., Losito, L., Citterio, A., & Bassi, M. T. (2018). . Frontiers in neurology, 91078. https://doi.org/10.3389/fneur.2018.01078
Simone, Marta, et al. "." Frontiers in neurology vol. 9 (2018): 1078. doi: https://doi.org/10.3389/fneur.2018.01078
Simone M, Trabacca A, Panzeri E, Losito L, Citterio A, Bassi MT. . Front Neurol. 2018 Dec 07;9:1078. doi: 10.3389/fneur.2018.01078. eCollection 2018. PMID: 30581417; PMCID: PMC6293196.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 176 entries